Using a serious game for gait rehabilitation in children with cerebral palsy

Serious Game-based Intervention in Gait Rehabilitation for Children With Cerebral Palsy: Randomized Control Trial

Not applicable Interventional Fondation Ellen Poidatz · NCT04837105

This study tests if a fun augmented reality game can help improve walking skills in children with cerebral palsy after their surgery, compared to regular rehab methods.

Quick facts

PhaseNot applicable
Study typeInterventional
Enrollment14 (estimated)
Ages10 Years to 18 Years
SexAll
SponsorFondation Ellen Poidatz Academic / other
Locations1 site (Saint-Fargeau-Ponthierry, Île-de-France Region)
Trial IDNCT04837105 on ClinicalTrials.gov

What this trial studies

This clinical trial investigates the effectiveness of a serious game called ARRoW-CP, designed for augmented reality headsets, in improving gait rehabilitation for children with cerebral palsy following multi-level surgery. Participants are divided into two groups: one receiving traditional rehabilitation combined with treadmill training, and the other engaging in gait training using the ARRoW-CP game. The study aims to assess the impact of this innovative approach on gait parameters, functional abilities, and patient motivation. The trial is conducted at the Fondation Ellen Poidatz in France.

Who should consider this trial

Good fit: Ideal candidates are children aged 10 to 17 years with a clinical diagnosis of cerebral palsy who have undergone multi-level surgery of the lower limbs.

Not a fit: Patients with photosensitive epilepsy or those who do not meet the inclusion criteria may not benefit from this study.

Why it matters

Potential benefit: If successful, this intervention could significantly enhance gait rehabilitation outcomes and overall functional abilities for children with cerebral palsy.

How similar studies have performed: While the use of serious games in rehabilitation is a growing field, this specific approach using augmented reality for gait rehabilitation in children with cerebral palsy is relatively novel.

Eligibility criteria

Show full inclusion / exclusion criteria
Inclusion Criteria:

* A clinical diagnosis of CP mentioned in the medical record
* Minor child for the entire duration of the protocol, i.e. between 10 and 17 years of age (the child must be less than 18 years of age at the time of the last check-up scheduled 1 year after inclusion in the study)
* Global Motor Function Classification System (GMFCS) levels I to III
* Functional Mobility Scale 50 meters rating superior or equal to 2 (ability to walk on 50m using a walker or frame without help from another person)
* Ability to cooperate, understand and follow simple instructions to play.
* Patient affiliated to the French social security system
* Voluntary patient whose parents have given their consent for their child to participate in the study
* Patient who has undergone multisite surgery of the lower limbs including bone procedures at least 7 weeks before the start of the procedure

Exclusion Criteria:

* A diagnosis of photosensitive epilepsy mentioned in the medical file AND/OR a mention in the child's medical file or by the parents or by the child of a history of epileptic seizures occurring during the practice of a video game
* A visual, cognitive or auditory impairment at a level that would interfere with playing the game. The patient must have normal or corrected vision and hearing.

Where this trial is running

Saint-Fargeau-Ponthierry, Île-de-France Region

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions Cerebral PalsyGait Disorders, Neurologicphysiotherapygait rehabilitationserious gamemulti level surgery
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.